Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography–high-resolution tandem mass spectrometry
Journal of Analytical Toxicology · 2024
DOI: 10.1093/jat/bkae022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2024. Verfasst von Florian Pitterl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Legal Medicine, Medical University of Innsbruck, Muellerstrasse 44, Innsbruck 6020, Austria. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Substance Abuse Detection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hexahydrocannabinol (HHC), 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol, is a semi-synthetic cannabinoid that has presented challenges to analytical laboratories due to its emergence and spread in the drug market. The lack of information on human pharmacokinetics hinders the development and application of presumptive and confirmatory tests for reliably detecting HHC consumption. To address this knowledge gap, we report the analytical results obtained from systematic forensic toxicological analysis of body-fluid samples collected from three individuals suspected of drug-impaired driving after HHC consumption. Urine and plasma samples were analyzed using non-targeted liquid chromatography–high-resolution tandem mass spectrometry. The results provided evidence that HHC undergoes biotransformation reactions similar to other well-characterized cannabinoids, such as ∆9-tetrahydrocannabinol or cannabidiol. Notably, HHC itself was only detectable in plasma samples, not in urine samples. The observed Phase I reactions involved oxidation of C11 and the pentyl side chain, leading to corresponding hydroxylated and carboxylic acid species. Additionally, extensive glucuronidation of HHC and its Phase I metabolites was evident.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Legal Medicine, Medical University of Innsbruck, Muellerstrasse 44, Innsbruck 6020, Austria.
- Forensic Chemistry Division, Cayman Chemical Company, 1180 E Ellsworth Rd., Ann Arbor, MI 48108, USA.
- Core Facility Metabolomics, Medical University of Innsbruck, Muellerstrasse 44, Innsbruck 6020, Austria.
ORCID-Profile: Herbert Oberacher
Zitieren
APA
Pitterl, F., Pavlic, M., Liu, J., & Oberacher, H. (2024). Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography–high-resolution tandem mass spectrometry. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae022
Vancouver
Pitterl F, Pavlic M, Liu J, Oberacher H. Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography–high-resolution tandem mass spectrometry. Journal of Analytical Toxicology. 2024. doi:10.1093/jat/bkae022
BibTeX
@article{Pitterl2024,
author = {Pitterl, Florian and Pavlic, Marion and Liu, Jianmei and Oberacher, Herbert},
title = {Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography–high-resolution tandem mass spectrometry},
journal = {Journal of Analytical Toxicology},
year = {2024},
doi = {10.1093/jat/bkae022}
}
EUVIMED